{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T18:04:35Z","timestamp":1775066675942,"version":"3.50.1"},"reference-count":26,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The Framingham Steatosis Index (FSI) is a diagnostic indicator of hepatic steatosis. Although prior studies have established associations between hepatic steatosis and chronic kidney disease (CKD) and between FSI and CKD, the association between FSI and proteinuria remains unexplored. This study investigated the association between FSI and albuminuria, addressing this research gap.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Patients and methods<\/jats:title>\n                    <jats:p>Data were obtained from the National Health and Nutrition Examination Survey (NHANES) database. The association between FSI and albuminuria was examined using multivariable logistic regression and stratified analyses. Nonlinearity was assessed using smoothing curves, and inflection points were located with a recursive algorithm. Subgroup analyses were conducted to evaluate the consistency of the association between FSI and albuminuria across different strata. Finally, propensity score matching (PSM) was applied to reduce potential confounding and enhance the robustness of the findings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In model 3, which adjusted for all covariates, the odds ratio (OR) for the association between FSI and albuminuria was 1.13 (95% CI: 1.09\u20131.18). Smooth curve fitting demonstrated a U-shaped relationship between FSI and albuminuria. Threshold analysis identified an inflection point at an FSI value of \u22123.22 to further characterize this relationship. Subgroup analyses showed directionally consistent associations across strata. The U-shaped relationship between FSI and albuminuria remained robust after applying PSM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our study identified a U-shaped relationship between FSI and albuminuria.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0337104","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T18:27:01Z","timestamp":1763663221000},"page":"e0337104","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association of Framingham Steatosis Index with Albuminuria: A cross-sectional study"],"prefix":"10.1371","volume":"20","author":[{"given":"Dongli","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4913-1403","authenticated-orcid":true,"given":"You","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,11,20]]},"reference":[{"key":"pone.0337104.ref001","doi-asserted-by":"crossref","first-page":"1462789","DOI":"10.3389\/fnut.2024.1462789","article-title":"Prognostic nutritional index and albuminuria in adults aged 20\u2009years and above: a cross-sectional analysis in the United States","volume":"11","author":"Z Jiang","year":"2024","journal-title":"Front Nutr"},{"issue":"11","key":"pone.0337104.ref002","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1038\/s41591-019-0627-8","article-title":"Glomerular filtration rate by differing measures, albuminuria and prediction of cardiovascular disease, mortality and end-stage kidney disease","volume":"25","author":"JS Lees","year":"2019","journal-title":"Nat Med"},{"issue":"2","key":"pone.0337104.ref003","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S2213-8587(18)30313-9","article-title":"Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies","volume":"7","author":"J Coresh","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"13","key":"pone.0337104.ref004","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1093\/eurheartj\/ehac683","article-title":"Prevention of cardiorenal damage: importance of albuminuria","volume":"44","author":"LM Ruilope","year":"2023","journal-title":"Eur Heart J"},{"issue":"6","key":"pone.0337104.ref005","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1681\/ASN.0000000000000117","article-title":"Change in Albuminuria and GFR slope as joint surrogate end points for kidney failure: implications for phase 2 clinical trials in CKD","volume":"34","author":"HJL Heerspink","year":"2023","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"pone.0337104.ref006","article-title":"Development and Validation of the Framingham Steatosis Index to Identify Persons With Hepatic Steatosis","volume":"14","author":"MT Long","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"pone.0337104.ref007","doi-asserted-by":"crossref","first-page":"101567","DOI":"10.1016\/j.clinre.2020.10.011","article-title":"The ability of the framingham steatosis index (FSI) to predict non-alcoholic fatty liver disease (NAFLD): a cohort study","volume":"45","author":"N Motamed","year":"2021","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"pone.0337104.ref008","doi-asserted-by":"crossref","first-page":"1510327","DOI":"10.3389\/fpsyt.2024.1510327","article-title":"The curvilinear relationship between Framingham Steatosis Index and depression: insights from a nationwide study","volume":"15","author":"C Jiang","year":"2025","journal-title":"Front Psychiatry"},{"key":"pone.0337104.ref009","doi-asserted-by":"crossref","first-page":"1163052","DOI":"10.3389\/fcvm.2023.1163052","article-title":"Predictive value of the Framingham steatosis index for cardiovascular risk: a nationwide population-based cohort study","volume":"10","author":"YK Cho","year":"2023","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"pone.0337104.ref010","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1136\/gutjnl-2020-323082","article-title":"Non-alcoholic fatty liver disease and risk of incident chronic kidney disease: an updated meta-analysis","volume":"71","author":"A Mantovani","year":"2022","journal-title":"Gut"},{"key":"pone.0337104.ref011","doi-asserted-by":"crossref","first-page":"1518202","DOI":"10.3389\/fmed.2024.1518202","article-title":"Curvilinear association between Framingham Steatosis Index and chronic kidney disease: a nationwide cross-sectional study","volume":"11","author":"C Jiang","year":"2025","journal-title":"Front Med (Lausanne)"},{"issue":"10","key":"pone.0337104.ref012","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1161\/CIRCULATIONAHA.124.071079","article-title":"Albuminuria in Cardiovascular, Kidney, and Metabolic Disorders: A State-of-the-Art Review","volume":"151","author":"SE Claudel","year":"2025","journal-title":"Circulation"},{"issue":"5","key":"pone.0337104.ref013","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s40620-015-0177-1","article-title":"Liver steatosis and the risk of albuminuria: the multi-ethnic study of atherosclerosis","volume":"28","author":"RV Shah","year":"2015","journal-title":"J Nephrol"},{"issue":"1","key":"pone.0337104.ref014","article-title":"Fatty liver index, albuminuria and the association with chronic kidney disease: a population-based study in China","volume":"8","author":"K Sun","year":"2018","journal-title":"BMJ Open"},{"issue":"5","key":"pone.0337104.ref015","doi-asserted-by":"crossref","first-page":"698","DOI":"10.4093\/dmj.2020.0118","article-title":"Albuminuria is associated with steatosis burden in patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease","volume":"45","author":"E Han","year":"2021","journal-title":"Diabetes Metab J"},{"issue":"2","key":"pone.0337104.ref016","doi-asserted-by":"crossref","first-page":"285","DOI":"10.7150\/ijms.28264","article-title":"Non-alcoholic fatty liver disease is associated with low-grade albuminuria in men without diabetes mellitus","volume":"16","author":"SH Kang","year":"2019","journal-title":"Int J Med Sci"},{"issue":"2","key":"pone.0337104.ref017","article-title":"Effect of MAFLD on albuminuria and the interaction between MAFLD and diabetes on albuminuria","volume":"16","author":"Y Liu","year":"2024","journal-title":"J Diabetes"},{"issue":"1","key":"pone.0337104.ref018","doi-asserted-by":"crossref","first-page":"5774","DOI":"10.1038\/s41598-020-62841-y","article-title":"Effects of low skeletal muscle mass and sarcopenic obesity on albuminuria: a 7-year longitudinal study","volume":"10","author":"JH Yoo","year":"2020","journal-title":"Sci Rep"},{"issue":"6","key":"pone.0337104.ref019","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1161\/HYPERTENSIONAHA.110.156380","article-title":"Orthostatic hypotension and incident chronic kidney disease: the atherosclerosis risk in communities study","volume":"56","author":"N Franceschini","year":"2010","journal-title":"Hypertension"},{"issue":"6","key":"pone.0337104.ref020","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.semnephrol.2019.10.008","article-title":"The role of hypoxia in ischemic chronic kidney disease","volume":"39","author":"SC Textor","year":"2019","journal-title":"Semin Nephrol"},{"issue":"4","key":"pone.0337104.ref021","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1002\/jcsm.13275","article-title":"Association between sarcopenia and frailty in elderly patients with chronic kidney disease","volume":"14","author":"C Wang","year":"2023","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"2","key":"pone.0337104.ref022","doi-asserted-by":"crossref","first-page":"2367028","DOI":"10.1080\/0886022X.2024.2367028","article-title":"Elucidating the causal nexus and immune mediation between frailty and chronic kidney disease: integrative multi-omics analysis","volume":"46","author":"G Zheng","year":"2024","journal-title":"Ren Fail"},{"issue":"1","key":"pone.0337104.ref023","article-title":"Metabolic syndrome severity score and the progression of CKD","volume":"52","author":"M Wu","year":"2022","journal-title":"Eur J Clin Invest"},{"key":"pone.0337104.ref024","doi-asserted-by":"crossref","first-page":"1215055","DOI":"10.3389\/fendo.2023.1215055","article-title":"The relationship between triglyceride-glucose index and albuminuria in United States adults","volume":"14","author":"Z Wang","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"pone.0337104.ref025","doi-asserted-by":"crossref","first-page":"1179551418792257","DOI":"10.1177\/1179551418792257","article-title":"The impact of insulin resistance and chronic kidney disease on inflammation and cardiovascular disease","volume":"11","author":"CE Kosmas","year":"2018","journal-title":"Clin Med Insights Endocrinol Diabetes"},{"key":"pone.0337104.ref026","doi-asserted-by":"crossref","first-page":"1457598","DOI":"10.3389\/fendo.2024.1457598","article-title":"Elevated ALT\/AST ratio as a marker for NAFLD risk and severity: insights from a cross-sectional analysis in the United States","volume":"15","author":"Y Xuan","year":"2024","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0337104","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T18:27:07Z","timestamp":1763663227000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0337104"}},"subtitle":[],"editor":[{"given":"Hassan","family":"Elahi","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":26,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0337104","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,20]]}}}